vs
Orion Properties Inc.（ONL）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是Orion Properties Inc.的2.0倍（$69.8M vs $35.2M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs -101.7%，领先485.7%），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs -8.2%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs -13.6%）
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
ONL vs RIGL — 直观对比
营收规模更大
RIGL
是对方的2.0倍
$35.2M
营收增速更快
RIGL
高出29.4%
-8.2%
净利率更高
RIGL
高出485.7%
-101.7%
两年增速更快
RIGL
近两年复合增速
-13.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $35.2M | $69.8M |
| 净利润 | $-35.8M | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | -101.5% | 33.2% |
| 净利率 | -101.7% | 384.0% |
| 营收同比 | -8.2% | 21.2% |
| 净利润同比 | -9.3% | 1769.2% |
| 每股收益（稀释后） | $-0.63 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ONLRIGL
| Q4 25 | $35.2M | $69.8M | ||
| Q3 25 | $37.1M | $69.5M | ||
| Q2 25 | $37.3M | $101.7M | ||
| Q1 25 | $38.0M | $53.3M | ||
| Q4 24 | $38.4M | $57.6M | ||
| Q3 24 | $39.2M | $55.3M | ||
| Q2 24 | $40.1M | $36.8M | ||
| Q1 24 | $47.2M | $29.5M |
净利润ONLRIGL
| Q4 25 | $-35.8M | $268.1M | ||
| Q3 25 | $-69.0M | $27.9M | ||
| Q2 25 | $-25.1M | $59.6M | ||
| Q1 25 | $-9.4M | $11.4M | ||
| Q4 24 | $-32.8M | $14.3M | ||
| Q3 24 | $-10.2M | $12.4M | ||
| Q2 24 | $-33.8M | $-1.0M | ||
| Q1 24 | $-26.2M | $-8.2M |
毛利率ONLRIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率ONLRIGL
| Q4 25 | -101.5% | 33.2% | ||
| Q3 25 | -185.8% | 40.9% | ||
| Q2 25 | -67.1% | 60.1% | ||
| Q1 25 | -24.4% | 23.9% | ||
| Q4 24 | -85.4% | 28.9% | ||
| Q3 24 | -25.9% | 25.4% | ||
| Q2 24 | -84.1% | 1.2% | ||
| Q1 24 | -55.4% | -23.6% |
净利率ONLRIGL
| Q4 25 | -101.7% | 384.0% | ||
| Q3 25 | -186.0% | 40.2% | ||
| Q2 25 | -67.3% | 58.6% | ||
| Q1 25 | -24.6% | 21.5% | ||
| Q4 24 | -85.4% | 24.9% | ||
| Q3 24 | -26.1% | 22.5% | ||
| Q2 24 | -84.2% | -2.8% | ||
| Q1 24 | -55.6% | -27.9% |
每股收益（稀释后）ONLRIGL
| Q4 25 | $-0.63 | $14.11 | ||
| Q3 25 | $-1.23 | $1.46 | ||
| Q2 25 | $-0.45 | $3.28 | ||
| Q1 25 | $-0.17 | $0.63 | ||
| Q4 24 | $-0.59 | $0.82 | ||
| Q3 24 | $-0.18 | $0.70 | ||
| Q2 24 | $-0.60 | $-0.06 | ||
| Q1 24 | $-0.47 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $22.4M | $155.0M |
| 总债务越低越好 | $465.0M | $52.5M |
| 股东权益账面价值 | $623.2M | $391.5M |
| 总资产 | $1.2B | $513.6M |
| 负债/权益比越低杠杆越低 | 0.75× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资ONLRIGL
| Q4 25 | $22.4M | $155.0M | ||
| Q3 25 | $32.6M | $137.1M | ||
| Q2 25 | $17.4M | $108.4M | ||
| Q1 25 | $9.4M | $77.1M | ||
| Q4 24 | $15.6M | $77.3M | ||
| Q3 24 | $16.6M | $61.1M | ||
| Q2 24 | $24.2M | $49.1M | ||
| Q1 24 | $23.6M | $49.5M |
总债务ONLRIGL
| Q4 25 | $465.0M | $52.5M | ||
| Q3 25 | $483.0M | $60.0M | ||
| Q2 25 | $483.0M | $60.0M | ||
| Q1 25 | $505.0M | $60.0M | ||
| Q4 24 | $492.0M | $60.0M | ||
| Q3 24 | $485.0M | $60.0M | ||
| Q2 24 | $462.0M | $60.0M | ||
| Q1 24 | $471.0M | $60.0M |
股东权益ONLRIGL
| Q4 25 | $623.2M | $391.5M | ||
| Q3 25 | $658.8M | $117.6M | ||
| Q2 25 | $728.0M | $81.9M | ||
| Q1 25 | $753.5M | $18.6M | ||
| Q4 24 | $763.9M | $3.3M | ||
| Q3 24 | $800.9M | $-14.6M | ||
| Q2 24 | $816.1M | $-29.9M | ||
| Q1 24 | $854.6M | $-31.7M |
总资产ONLRIGL
| Q4 25 | $1.2B | $513.6M | ||
| Q3 25 | $1.2B | $242.5M | ||
| Q2 25 | $1.3B | $206.7M | ||
| Q1 25 | $1.3B | $176.0M | ||
| Q4 24 | $1.3B | $164.0M | ||
| Q3 24 | $1.4B | $139.4M | ||
| Q2 24 | $1.3B | $128.4M | ||
| Q1 24 | $1.4B | $126.5M |
负债/权益比ONLRIGL
| Q4 25 | 0.75× | 0.13× | ||
| Q3 25 | 0.73× | 0.51× | ||
| Q2 25 | 0.66× | 0.73× | ||
| Q1 25 | 0.67× | 3.23× | ||
| Q4 24 | 0.64× | 18.25× | ||
| Q3 24 | 0.61× | — | ||
| Q2 24 | 0.57× | — | ||
| Q1 24 | 0.55× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $23.6M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流ONLRIGL
| Q4 25 | $23.6M | $22.0M | ||
| Q3 25 | $5.7M | $24.0M | ||
| Q2 25 | $11.6M | $30.5M | ||
| Q1 25 | $-2.2M | $-893.0K | ||
| Q4 24 | $54.3M | $14.5M | ||
| Q3 24 | $13.8M | $21.7M | ||
| Q2 24 | $17.0M | $302.0K | ||
| Q1 24 | $11.0M | $-5.0M |
现金转化率ONLRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | — | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.75× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
